An engineered probiotic just wiped out 43% of colorectal tumors in new trial
Have you ever wondered whether a cancer treatment could be delivered directly to a tumor instead of circulating throughout the entire body? Scientists are exploring exactly that possibility with an unusual tool: a genetically engineered probiotic bacterium. In a recent preclinical study, researchers modified Escherichia coli Nissle 1917, a strain known for its probiotic properties, …